Math model may Fine-Tune radiation for throat cancer patients
NCT ID NCT03656133
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a mathematical model could help doctors choose the best radiation schedule for people with HPV-positive throat cancer. The goal was to see if personalized dosing could shrink tumors faster than standard treatment. Fifty-five adults took part, and researchers measured tumor shrinkage after four weeks and complete response after two to three months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV-POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Robotic surgery may spare throat cancer patients from chemo and radiation
- Vaccine trains immune system to fight HPV-Positive head and neck tumors
- New drug combo targets HPV-Driven cancers in phase II trial
- New Vaccine-Drug combo aims to tame HPV throat cancer with less radiation
- New sedative could speed recovery for ventilator patients
- Can light be the new shield against radiation mouth sores?